Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories
-
iBio, Inc. (IBIO) Announces $15.0 Million Private Placement
-
Immuneering Corporation (IMRX) PT Lowered to $16 at Chardan Capital Markets
-
Presto (PRST) Announces Pricing of $1.2M Registered Direct Offering Priced above Nasdaq Minimum Price
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $2.50 at Chardan Capital Markets
-
Chardan Capital Markets Starts Metagenomi Inc (MGX) at Buy
-
Collective Audience (CAUD) Announces Share and Warrant Offering
-
BitFuFu Closes Merger with Arisz Acquisition (ARIZU)
-
Presto (PRST) Prices 8.53M Share Offering at $0.25/sh
-
Avidity Biosciences Inc. (RNA) Prices 15.22M Share Offering at $16.50/sh
-
Chardan Capital Markets Upgrades Outlook Therapeutics Incs. (OTLK) to Buy, 'Outlook Is Bright Again'
-
Prime Medicine (PRME) Prices Upsized 19.2M Share Offering at $6.25/sh
-
Prime Medicine (PRME) Announces Proposed $125M Share Offering
-
Adagio Medical to Go Public via Merger with ARYA Sciences Acquisition Corp IV (ARYD)
-
Metagenomi (MGX) Closes $93.75M IPO
-
Presto (PRST) Raises $6M, Wins Final Appeal Against XAC
-
Chardan Downgrades Synlogic Inc. (SYBX) to Neutral 'on Early Termination of Synpheny-3 Trial'
-
Metagenomi (MGX) Prices 6.25M Share IPO at $15/sh
-
4D Molecular Therapeutics (FDMT) PT Raised to $38 at Chardan, 'Phase II wAMD Data Set Up a Competitive GT Profile'
-
Silence Therapeutics (SLN) Prices 5.71M Share Offering at $21/sh
-
Collective Audience (CAUD) Announces 3.22M Share and Warrant Offering by Selling Stockholders
-
Metagenomi (MGX) Announces Proposed IPO
-
Bruush Oral Care (BRSH) and Arrive Technology Announce Agreement and Plan of Merger
-
Bayview Acquisition Corp (BAYAU) Prices 6M Unit IPO at $10/unit
-
Coya Therapeutics (COYA) Announces $26.5 Million Private Placement
-
Chardan Capital Markets Starts Lexeo Therapeutics (LXEO) at Buy
-
Chardan Capital Markets Starts Notable Labs, Inc. (NTBL) at Buy on the 'potential of its proprietary Predictive Precision Medicine Platform'
-
Global Lights Acquisition Corp (GLACU) Announces Pricing of $60 Million Initial Public Offering
-
Chardan Capital Markets Upgrades ProQR Therapeutics N.V. (PRQR) to Buy
-
Sonnet BioTherapeutics (SONN) Announces Pricing of $4.55 Million Underwritten Public Offering
-
SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million
-
Synlogic (SYBX) Prices 7.39M Share Offering at $2.84/sh
-
Form SC 13D Gardiner Healthcare Acqu Filed by: Chardan Gardiner LLC
-
Inpixon (INPX) Enters into Definitive Merger Agreement with XTI Aircraft Company
-
Better Therapeutics (BTTX) Announces $6.7M Financing at $0.77/sh
-
Chardan Capital Markets Starts 4D Molecular Therapeutics (FDMT) at Buy
-
Sonnet BioTherapeutics (SONN) Prices 5M Share Offering at $0.45/sh
-
Dragonfly Energy Holdings (DFLI) Prices 10M Share Offering at $2/sh
-
Chardan Capital Markets Starts Zura Bio (ZURA)Buy
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
ANEW MEDICAL (LEAS) to Merge with Redwoods Acquisition Corp (RWOD)
-
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement
-
Zura Bio (ZURA) Completes $80M Financing Deal
-
Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
ANEW MEDICAL, INC. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Presto (PRST) Unlocks $20M of Cash in PIPE Transaction